Clopidogrel Market: Change in People’s Lifestyle to Fuel Demand Globally, says TMR Research

San Francisco, California, October 23, 2018 – Clopidogrel is used in antiplatelet therapy since a very long time, and has become a preferred choice of the medical practitioners, who treat people suffering from percutaneous coronary intervention or cute coronary syndrome. Recently a report is published by TMR Research, named “Clopidogrel Market – Global Industry Analysis, Size, Share, Trends and Forecast 2017 – 2025.”

Get Sample Copy of this Report @

Among several of them, the major factor boosting the demand for clopidogrel is the whooping rise in population over the world who are experiencing cardiovascular ailments and similar issues. Furthermore, the changing way of life and rise in number of patients suffering from cardiovascular ailments among the developing economies in the Asia Pacific area are as well anticipated that to emerge as the major buyers for clopidogrel in the span of forecast period from 2017 to 2025. Additionally, the patent expiry of clopidogrel medicine is foreseen to open various door for business for different pharmaceutical organizations to enter into the production of clopidogrel medicine.

In the present scenario, Europe and North America add to the greatest demand for clopidogrel, inferable from factors, for example, strong infrastructure in healthcare sector and high cost-effectiveness of the residents in the mentioned regions. Be that as it may, a few nations in the Asia Pacific region, for example, India, China, and Japan are forcefully moving in the direction of enhancing their medical services industry with the assistance of positive strategies by the respective governments and surge in disposable income among the population of the countries. Asia Pacific region has around 50% of the global population, which makes for a high amount of patient base. Moreover, these locales likewise have gifted work requiring little to no effort which is empowering players in the market to contribute effectively and tap the neglected demands.

Read Comprehensive Overview of Report @

The major players operating in the global clopidogrel market include Dr Reddy’s, Pfizer, Apotex Corp, Aurobindo Pharma, Roxane Laboratories, Sun Pharma, and Torrent Pharmaceuticals.

Better Healthcare Facilities Augments Demand for Clopidogrel

San Francisco, California, July 04, 2017: TMR Research opens up an insightful discussion about the global Clopidogrel market through its latest publication. The research report, titled “Clopidogrel Market – Global Industry Analysis, Size, Share, Trends and Forecast 2017 – 2025,” presents a comprehensive outlook of the overall market and the assessment of the factors impacting its trajectory. According to the research report, the demand for Clopidogrel is expected to remain high due to its growing number of applications and the early head start it has had. Today, Clopidogrel is extensively used to treat patients suffering from morbidity and mortality due to acute myocardial infarction, coronary syndrome, and other indications. Owing to this very reason, the drug has an indomitable presence in the global market.

Analysts state that the demand for Clopidogrel is likely to remain steady in the near future as it extremely easy to use, excellent tolerability, and low rate of side-effects. This antiplatelet agent is also being used for reducing the frequency of atherosclerotic events in patients who might be suffering from heart diseases. Despite the strong growth drivers, the market faces some tough challenges. The key restraint for the global market is the presence of large number of generic drugs in the global market that act as substitutes. These substitutes have been steadily eating into the profit margins of Clopidogrel market, posing as a significant challenge for the same.

In terms of geography, the global Clopidogrel market is segmented into Asia Pacific, North America, Europe, and Rest of the World. Of these Europe and North America have a stronghold in the overall market as the regions boast well-established healthcare infrastructure setup. Additionally, the improving accessibility to healthcare facilities and affordability of medical care is also driving the regional markets. The research report states that the demand for Clopidogrel is also expected to augment all across Asia Pacific due to an ever-growing population base. The rising investments in Asia Pacific and the huge unmet medical demands are expected to bolster the growth of this regional market.

Some of the leading players operating in the global Clopidogrel market are Some of the key players in the global Clopidogrel market are Apotex Corp, Torrent Pharmaceuticals, Pfizer, Dr Reddy’s, Aurobindo Pharma, Roxane Laboratories, and Sun Pharma. The research report provides a detailed analysis the competitive landscape present in the global market along with the assessment of the various factors such as threat from new entrants and the substitutes. The publication also includes a study of the financial overview of the overall market, research and development statuses of several companies operating in the global market, and business and marketing strategies. The research report also includes comments and recommendations from market experts to help readers gain a valuable insight of the market.